178 related articles for article (PubMed ID: 28435276)
1. Clinical and biochemical study of d-serine metabolism among schizophrenia patients.
El-Tallawy HN; Saleem TH; El-Ebidi AM; Hassan MH; Gabra RH; Farghaly WM; Abo El-Maali N; Sherkawy HS
Neuropsychiatr Dis Treat; 2017; 13():1057-1063. PubMed ID: 28435276
[TBL] [Abstract][Full Text] [Related]
2. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
3. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
4. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
5. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
6. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
Kuo CY; Lin CH; Lane HY
CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
9. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
10. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
MacKay MB; Kravtsenyuk M; Thomas R; Mitchell ND; Dursun SM; Baker GB
Front Psychiatry; 2019; 10():25. PubMed ID: 30787885
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
12. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
13. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.
Smith SM; Uslaner JM; Hutson PH
Open Med Chem J; 2010 May; 4():3-9. PubMed ID: 20648222
[TBL] [Abstract][Full Text] [Related]
14. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.
Boks MP; Rietkerk T; van de Beek MH; Sommer IE; de Koning TJ; Kahn RS
Eur Neuropsychopharmacol; 2007 Sep; 17(9):567-72. PubMed ID: 17250995
[TBL] [Abstract][Full Text] [Related]
15. Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase.
Molla G
Front Mol Biosci; 2017; 4():80. PubMed ID: 29250527
[TBL] [Abstract][Full Text] [Related]
16. D-Serine Metabolism and Its Importance in Development of
Ito T; Hamauchi N; Hagi T; Morohashi N; Hemmi H; Sato YG; Saito T; Yoshimura T
Front Microbiol; 2018; 9():784. PubMed ID: 29740415
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
[TBL] [Abstract][Full Text] [Related]
18. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
Yamada K; Ohnishi T; Hashimoto K; Ohba H; Iwayama-Shigeno Y; Toyoshima M; Okuno A; Takao H; Toyota T; Minabe Y; Nakamura K; Shimizu E; Itokawa M; Mori N; Iyo M; Yoshikawa T
Biol Psychiatry; 2005 Jun; 57(12):1493-503. PubMed ID: 15953485
[TBL] [Abstract][Full Text] [Related]
19. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.
Habl G; Zink M; Petroianu G; Bauer M; Schneider-Axmann T; von Wilmsdorff M; Falkai P; Henn FA; Schmitt A
J Neural Transm (Vienna); 2009 Dec; 116(12):1657-65. PubMed ID: 19823762
[TBL] [Abstract][Full Text] [Related]
20. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
